FDA Inspection 1092223 — Olga Sleglova, M.D.
The FDA completed an inspection of Olga Sleglova, M.D. on May 17, 2019 in Prague 28. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Prague 28 (Czech Republic)
Additional Details
Clinical Investigator (CI)